Living donor renal transplant in a patient with end-stage renal disease due to Hermansky-Pudlak syndrome
- PMID: 30317187
- PMCID: PMC6194378
- DOI: 10.1136/bcr-2017-223376
Living donor renal transplant in a patient with end-stage renal disease due to Hermansky-Pudlak syndrome
Abstract
Hermansky-Pudlak syndrome (HPS) is a rare genetic disorder characterised by oculocutaneous albinism, bleeding diathesis and end-stage renal disease (ESRD), due to interstitial deposition of ceroid lipofuscin. Renal transplantation is potentially a definitive treatment option for patients with ESRD due to HPS. Herein, we describe the case of a 55-year-old male patient with HPS that successfully underwent a living donor kidney transplant. We also emphasise the importance of multidisciplinary input during the preoperative, perioperative and postoperative phases in this high-risk clinical scenario.
Keywords: haematology (incl blood transfusion); renal transplantation; transplantation; urological surgery.
© BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical